In addition to the above-described correlations between FGF19 and CRP, we also observed other correlations: four positive correlations (between hemoglobin and FGF19 24 h after transplantation in HCC patients, between hemoglobin and FGF19 2 weeks after transplantation in HBV patients, and between ALT/total bilirubin and FGF19 2 weeks after transplantation in the HCC group) and one negative correlation (between AST and FGF19 2 weeks after transplantation in ALD patients). The gene discussed is FGF19; the disease is hepatocellular carcinoma.